Key shareholder adviser backs Cigna-Express Scripts deal

Cigna's plan to buy pharmacy benefit manager Express Scripts for around $52 billion has received a big endorsement a few days after activist investor Carl Icahn urged shareholders to reject it.

The proxy advisory firm Institutional Shareholder Services said Friday that stock owners should vote for the deal later this month, calling it financially compelling.

Large institutional shareholders rely on ISS and similar firms to help them decide how to vote on certain company proposals.

Icahn had warned shareholders in an open letter that Cigna Corp. was paying too much for a company with a shaky future.

Pharmacy benefit managers like Express Scripts Holding Co. run prescription drug coverage for big employers and insurers, among other clients. They've become a focal point for criticism and regulatory scrutiny as drug prices rise.

Similar News

Australian official rejects criticisms of China investor ban

Aug 12, 2016

Australia's treasurer has rejected accusations that the true reason his government plans to ban Chinese bidders from leasing a Sydney electricity grid is to appease influential lawmakers with xenophobic views

Arianna Huffington signs off at The Huffington Post

Aug 11, 2016

Arianna Huffington is signing off at The Huffington Post

Macy's plans to close 100 stores, boost online investment

Aug 11, 2016

Macy's says it plans to close about 100 stores next year and increase its investments online as the department store operator tries to become more nimble in an increasingly fierce market

Broaden